Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03618979 · ClinicalTrials.gov registry record · NA
A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain
A NA study, sponsored by Regenexx.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03618979: Clinical Trial NA study, sponsored by Regenexx.
NCT03618979 is a NA study that was terminated before completion, run by Regenexx. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03618979, a NA study, was terminated before completion, sponsored by Regenexx.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
To evaluate and compare the effectiveness of 3 different injection treatments on multifidus atrophy and lower back pain.
Primary Outcome
Change in multifidus atrophy from baseline MRI
Interventions
- BIOLOGICAL PPP treatment
- BIOLOGICAL PRP treatment
- BIOLOGICAL PRP and PL Combo treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-05-02 |
| Est. Completion | 2022-06-29 |
| Phase | NA |
Why NCT03618979 stopped before completion
NCT03618979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which PPP treatment is the first listed.
NCT03618979 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03618979 about?
NCT03618979 is a clinical study titled "A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain". To evaluate and compare the effectiveness of 3 different injection treatments on multifidus atrophy and lower back pain.
What is the current status of trial NCT03618979?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2019-05-02. Estimated completion is 2022-06-29.
What interventions are being tested in trial NCT03618979?
The interventions under investigation include: PPP treatment (BIOLOGICAL), PRP treatment (BIOLOGICAL), PRP and PL Combo treatment (BIOLOGICAL).
Who is sponsoring clinical trial NCT03618979?
This trial is sponsored by Regenexx, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03618979's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI